Application no. and date | 19158371.5 (espacenet) (Federated) (European Patent Register), 20140912 | Patent/reg. no. and date | DK/EP 3546461, 20210811 | Publication date | 20191002 | Priority no. and date | US 201361904718 P, 20131115, US 201414208657, 20140313, US 201414341392, 20140725, WO PCT/US2014/048241, 20140725 | EP pub. no. and date |
EP 3546461 20191002 | Effective date | | Applicant/owner | Oncoceutics, Inc., 3675 Market Street Suite 200
Philadelphia, PA 19104, US | Applicant ref. no. | BARQ/P77009EPdiv1 | Inventor | POTTORF, Richard S., 7550 Prairie View Dr.
Indianapolis, IN 46526, US, NALLAGANCHU, Bhaskara Rao, 99 Nostrand Road
Hillsborough, NJ 08852, US, OLSON, Gary L., 1505 Coles Avenue
Mountainside, NJ 07092, US, STOGNIEW, Martin, 1870 Ferguson Lane
Blue Pell, PA 19422, US, ALLEN, Joshua E., 43 Chestnut St., Unit 311
New Haven, CT 06511, US | Representative | Potter Clarkson A/S, Regnbuepladsen 7, 1550 København V, DK | Opponent | | IPC Class | A61K 31/44 (2006.01) , A61K 31/519 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) , C07D 471/14 (2006.01) | Title | 7-BENZYL-4-(2-METHYLBENZYL)-2,4,6,7,8,9-HEXAHYDROIMIDAZO[1,2-A]PYRIDO[3,4-E]PYRIMIDIN-5(1H)-ONE, SALTS THEREOF AND METHODS OF USING THE SAME IN COMBINATION THERAPY | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|